Hiring?
Logo

QuadVantage

location_on

Midwest, USA

Short Summary

New Gold Standard: Transforming ACL Reconstruction Surgery: Superior strength · Reduced pain · Improved aesthetics · Reduced rehabilitation - Patented, Clinically tested technology. No additional FDA clearance required.

Overview

Target
US$1,000,000
Minimum
US$100,000
Investment Raised
N/A
Previous Rounds US$500,000
Stage MVP/Finished Product
Investor Role Any

Highlights

  • Clinical Trial Phase Complete, Granted Patents, Significant Differentiation
  • $1 Billion world market looking for a solution/ no real competition
  • Lower Pain, Quicker Recovery, More Durable ACL Reconstruction
  • Experienced management team/ low fixed cost high profit business model
  • Many viable exit paths/ easy bolt-on for strategic player
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Pro
4% raised

CellX Technologies

location_on North East,

Cell X Technologies, Inc. is a spin-out of the Cleveland Clinic by Dr George Muschler. “Cell X”, is an automated robotic cell processing platform, designed and engineered in collaboration with Parker Hannifin Corporation.

US$ 2,500,000

Target

US$ 10,000

Min per Investor

Pro
0% raised

Predictive Resp Monitor

location_on North East,

Linshom is the only FDA cleared device capable of delivering a complete predictive respiratory profile to the patient bedside. Respiratory rate, Tidal Volume, Minute Ventilation, and Apnea detection are all delivered continuously and in real time.

US$ 3,000,000

Target

US$ 25,000

Min per Investor

Pro
0% raised

Sigouros Systems, Inc.

location_on Midwest, USA

Featured on Fox Business News 12 times and CBS 2 times our disinfection entry systems has now gotten the attention of many new customers including the US government. We need investors to properly market and help with growth.

US$ 5,000,000

Target

US$ 250,000

Min per Investor

load one similar proposal